82 FR 27713 - National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 82, Issue 115 (June 16, 2017)
National Institutes of Health
Federal Register Volume 82, Issue 115 (June 16, 2017)
| Page Range | 27713-27714 | |
| FR Document | 2017-12483 |
[Federal Register Volume 82, Number 115 (Friday, June 16, 2017)] [Notices] [Pages 27713-27714] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-12483] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Initial Review Group; Neurological Sciences and Disorders A. Date: June 26-27, 2017. Time: 8:00 a.m. to 6:00 p.m. [[Page 27714]] Agenda: To review and evaluate grant applications. Place: Wyndham Grand Chicago River, 71 East Wacker Drive, Chicago, IL 60601. Contact Person: Natalia Strunnikova, Ph.D., Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892-9529, (301) 402-0288, [email protected]. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; BRAIN U19 Review Meeting. Date: July 6-7, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: St. Gregory Hotel, 2033 M Street NW., Washington, DC 20036. Contact Person: Natalia Strunnikova, Ph.D., Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892-9529, (301) 402-0288, [email protected]. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; F32 and K22 Review. Date: July 6-7, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Lorien Hotel and Spa, 1600 King Street, Alexandria, VA 22314. Contact Person: Jimok Kim, Ph.D., Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892-9529, (301) 496-9223, [email protected]. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; R35 Review. Date: July 10, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree by Hilton Washington DC--Crystal City, 300 Army Navy Drive, Arlington, VA 22202. Contact Person: Birgit Neuhuber, Ph.D., Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892-9529, [email protected]. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; NSD Member Conflict. Date: July 12, 2017. Time: 12:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Birgit Neuhuber, Ph.D., Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892-9529, [email protected]. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases. Date: July 14, 2017. Time: 8:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Lorien Hotel and Spa, 1600 King Street, Alexandria, VA 22314. Contact Person: Ana Olariu, Ph.D., Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892-9529, (301) 496-9223, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: June 12, 2017. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017-12483 Filed 6-15-17; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 82, No. 115 / Friday, June 16, 2017 / Notices 27713
Place: National Institutes of Health, 6701 DEPARTMENT OF HEALTH AND provisions set forth in sections
Rockledge Drive, Bethesda, MD 20892 HUMAN SERVICES 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
(Telephone Conference Call). as amended. The grant applications and
Contact Person: Syed M Quadri, Ph.D., National Institutes of Health the discussions could disclose
Scientific Review Officer, Center for confidential trade secrets or commercial
Scientific Review, National Institutes of National Institute of Allergy and property such as patentable materials,
Health, 6701 Rockledge Drive, Room 6210, Infectious Diseases; Notice of Closed and personal information concerning
MSC 7804, Bethesda, MD 20892, 301–435– Meeting
1211, quadris@csr.nih.gov.
individuals associated with the grant
Pursuant to section 10(d) of the applications, the disclosure of which
Name of Committee: Center for Scientific
Federal Advisory Committee Act, as would constitute a clearly unwarranted
Review Special Emphasis Panel; Small
Business: Computational, Modeling, and amended (5 U.S.C. App.), notice is invasion of personal privacy.
Biodata Management. hereby given of the following meeting. Name of Committee: National Institute on
Date: July 12, 2017. The meeting will be closed to the Minority Health and Health Disparities
Time: 8:00 a.m. to 6:00 p.m. public in accordance with the Special Emphasis Panel; Limited
Agenda: To review and evaluate grant provisions set forth in sections Competition: NIMHD Endowment Program
applications. for Increasing Research and Institutional
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Resources—(S21).
Place: Hilton Washington Embassy Row, as amended. The grant applications and Date: July 17, 2017.
2015 Massachusetts Ave., NW., Washington, the discussions could disclose Time: 12:00 p.m. to 5:00 p.m.
DC 20036. confidential trade secrets or commercial Agenda: To review and evaluate grant
Contact Person: Allen Richon, Ph.D., property such as patentable material, applications.
Scientific Review Officer, Center for and personal information concerning Place: National Institutes of Health,
Scientific Review, National Institutes of Gateway Plaza, 533J, 7201 Wisconsin
individuals associated with the grant
Health, 6701 Rockledge Drive, Room 6184, Avenue, Suite 533, Bethesda, MD 20814.
MSC 7892, Bethesda, MD 20892, 301–379–
applications, the disclosure of which
Contact Person: Deborah Ismond, Ph.D.,
9351, allen.richon@nih.hhs.gov. would constitute a clearly unwarranted Scientific Review Officer, Division of
invasion of personal privacy. Scientific Programs, National Institute on
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member Name of Committee: National Institute of Minority Health and Health Disparities,
Conflict: Drugs, Alcohol and Heavy Metals. Allergy and Infectious Diseases Special National Institutes of Health, 7201 Wisconsin
Date: July 12–13, 2017. Emphasis Panel NIAID; Investigator Initiated Ave., Suite 525, Bethesda, MD 20814, (301)
Program Project Application (P01). 594–2704, ismonddr@mail.nih.gov.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant Date: July 13, 2017. Dated: June 12, 2017.
applications. Time: 1:00 p.m. to 4:00 p.m.
David Clary,
Place: National Institutes of Health, 6701 Agenda: To review and evaluate grant
applications. Program Analyst, Office of Federal Advisory
Rockledge Drive, Bethesda, MD 20892 Committee Policy.
(Virtual Meeting). Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892 [FR Doc. 2017–12481 Filed 6–15–17; 8:45 am]
Contact Person: Michael Selmanoff, Ph.D.,
(Telephone Conference Call). BILLING CODE 4140–01–P
Scientific Review Officer, Center for
Contact Person: Paul A. Amstad, Ph.D.,
Scientific Review, National Institutes of
Scientific Review Officer, Scientific Review
Health, 6701 Rockledge Drive, Room 5164, Program, Division of Extramural Activities,
MSC 7844, Bethesda, MD 20892, 301–435– DEPARTMENT OF HEALTH AND
Room 3G41, NIAID/NIH/DHHS, 5601 Fishers HUMAN SERVICES
1119, selmanom@csr.nih.gov. Lane, Bethesda, MD 20892–7616, 240–669–
Name of Committee: Center for Scientific 5067, pamstad@niaid.nih.gov. National Institutes of Health
Review Special Emphasis Panel; Small (Catalogue of Federal Domestic Assistance
Business: Computational, Modeling, and Program Nos. 93.855, Allergy, Immunology, National Institute of Neurological
Biodata Management. and Transplantation Research; 93.856, Disorders and Stroke; Notice of Closed
Date: July 12, 2017. Microbiology and Infectious Diseases Meetings
Time: 8:00 a.m. to 6:00 p.m. Research, National Institutes of Health, HHS)
Agenda: To review and evaluate grant Pursuant to section 10(d) of the
Dated: June 12, 2017.
applications. Federal Advisory Committee Act, as
Place: Hilton Washington Embassy Row, Natasha M. Copeland,
amended (5 U.S.C. App.), notice is
2015 Massachusetts Ave., NW., Washington, Program Analyst, Office of Federal Advisory
hereby given of the following meetings.
DC 20036. Committee Policy.
The meetings will be closed to the
Contact Person: Ross D Shonat, Ph.D., [FR Doc. 2017–12480 Filed 6–15–17; 8:45 am] public in accordance with the
Scientific Review Officer, Center for BILLING CODE 4140–01–P provisions set forth in sections
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6172, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
MSC 7892, Bethesda, MD 20892, 301–435– as amended. The grant applications and
DEPARTMENT OF HEALTH AND the discussions could disclose
2786, ross.shonat@nih.hhs.gov. HUMAN SERVICES
(Catalogue of Federal Domestic Assistance confidential trade secrets or commercial
Program Nos. 93.306, Comparative Medicine; National Institutes of Health property such as patentable material,
93.333, Clinical Research, 93.306, 93.333, and personal information concerning
93.337, 93.393–93.396, 93.837–93.844, National Institute on Minority Health individuals associated with the grant
93.846–93.878, 93.892, 93.893, National and Health Disparities; Notice of applications, the disclosure of which
sradovich on DSK3GMQ082PROD with NOTICES
Institutes of Health, HHS) Closed Meeting would constitute a clearly unwarranted
Dated: June 12, 2017. invasion of personal privacy.
Pursuant to section 10(d) of the
Sylvia L. Neal, Name of Committee: National Institute of
Federal Advisory Committee Act, as Neurological Disorders and Stroke Initial
Program Analyst, Office of Federal Advisory amended (5 U.S.C. App.), notice is Review Group; Neurological Sciences and
Committee Policy. hereby given of the following meeting. Disorders A.
[FR Doc. 2017–12482 Filed 6–15–17; 8:45 am] The meeting will be closed to the Date: June 26–27, 2017.
BILLING CODE 4140–01–P public in accordance with the Time: 8:00 a.m. to 6:00 p.m.
VerDate Sep<11>2014 17:12 Jun 15, 2017 Jkt 241001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\16JNN1.SGM 16JNN1](https://thefederalregister.org/doc/82_FR_27828/page/1.svg)
![27714 Federal Register / Vol. 82, No. 115 / Friday, June 16, 2017 / Notices
Agenda: To review and evaluate grant Place: National Institutes of Health, Abuse Prevention (CSAP) aims to
applications. Neuroscience Center, 6001 Executive address two of SAMHSA’s top
Place: Wyndham Grand Chicago River, 71 Boulevard, Rockville, MD 20852 (Telephone substance abuse prevention priorities:
East Wacker Drive, Chicago, IL 60601. Conference Call).
Underage drinking (UAD; age 12 to 20)
Contact Person: Natalia Strunnikova, Contact Person: Birgit Neuhuber, Ph.D.,
Ph.D., Scientific Review Officer, Scientific Scientific Review Officer, Scientific Review and prescription drug misuse and abuse
Review Branch, NINDS/NIH/DHHS, Branch, NINDS/NIH/DHHS, Neuroscience (PDM; age 12 to 25) through the
Neuroscience Center, 6001 Executive Blvd., Center, 6001 Executive Blvd., Suite 3204, Division of State Program—Monitoring
Suite 3204, MSC 9529, Bethesda, MD 20892– MSC 9529, Bethesda, MD 20892–9529, and Reporting Tool. This data collection
9529, (301) 402–0288, Natalia.strunnikova@ neuhuber@ninds.nih.gov. will allow all DSP programs to report
nih.gov. Name of Committee: National Institute of into a standard tool that aligns with the
This notice is being published less than 15 Neurological Disorders and Stroke Special Strategic Prevention Framework model.
days prior to the meeting due to the timing Emphasis Panel; Clinical Trial Readiness for This request for data collection includes
limitations imposed by the review and Rare Neurological and Neuromuscular a revision from a previously approved
funding cycle. Diseases.
Date: July 14, 2017.
OMB instrument formally known as
Name of Committee: National Institute of Time: 8:00 p.m. to 6:00 p.m. Partnerships for Success-Management
Neurological Disorders and Stroke Special Agenda: To review and evaluate grant and Reporting Tool.
Emphasis Panel; BRAIN U19 Review applications. Monitoring data on SPF model will
Meeting. Place: Lorien Hotel and Spa, 1600 King allow SAMHSA project officers to
Date: July 6–7, 2017. Street, Alexandria, VA 22314. systematically collect data to monitor
Time: 8:00 a.m. to 6:00 p.m. Contact Person: Ana Olariu, Ph.D.,
Agenda: To review and evaluate grant their grant program performance and
Scientific Review Officer, Scientific Review outcomes along with grantee technical
applications. Branch, NINDS/NIH/DHHS, Neuroscience
Place: St. Gregory Hotel, 2033 M Street Center, 6001 Executive Blvd., Suite 3204,
assistance needs. In addition to
NW., Washington, DC 20036. MSC 9529, Bethesda, MD 20892–9529, (301) assessing activities related to the SPF
Contact Person: Natalia Strunnikova, 496–9223, ana.olariu@nih.gov. steps, the performance monitoring
Ph.D., Scientific Review Officer, Scientific instruments covered in this statement
(Catalogue of Federal Domestic Assistance
Review Branch, NINDS/NIH/DHHS, collect data to assess the following
Program Nos. 93.853, Clinical Research
Neuroscience Center, 6001 Executive Blvd., grantee required specific performance
Related to Neurological Disorders; 93.854,
Suite 3204, MSC 9529, Bethesda, MD 20892–
Biological Basis Research in the measures:
9529, (301) 402–0288, Natalia.strunnikova@
nih.gov.
Neurosciences, National Institutes of Health, • Number of training and technical
HHS) assistance activities per funded
Name of Committee: National Institute of
Neurological Disorders and Stroke Special Dated: June 12, 2017. community provided by the grantee to
Emphasis Panel; F32 and K22 Review. Sylvia L. Neal, support communities;
Date: July 6–7, 2017. Program Analyst, Office of Federal Advisory • Reach of training and technical
Time: 8:00 a.m. to 6:00 p.m. Committee Policy. assistance activities (numbers served)
Agenda: To review and evaluate grant [FR Doc. 2017–12483 Filed 6–15–17; 8:45 am] provided by the grantee;
applications.
BILLING CODE 4140–01–P
• Percentage of subrecipient
Place: Lorien Hotel and Spa, 1600 King communities that submit data to the
Street, Alexandria, VA 22314. grantee data system;
Contact Person: Jimok Kim, Ph.D.,
Scientific Review Officer, Scientific Review DEPARTMENT OF HEALTH AND • Number of sub-recipient
Branch, NINDS/NIH/DHHS, Neuroscience HUMAN SERVICES communities that improved on one or
Center, 6001 Executive Blvd., Suite 3204, more targeted NOMs indicators
MSC 9529, Bethesda, MD 20892–9529, (301) Substance Abuse and Mental Health (Outcome);
496–9223, Jimok.kim@nih.gov. Services Administration • Number of grantees who integrate
Name of Committee: National Institute of Prescription Drug Monitoring Data into
Neurological Disorders and Stroke Special Agency Information Collection their program needs assessment.
Emphasis Panel; R35 Review. Activities: Submission for OMB Changes to this package include the
Date: July 10, 2017. Review; Comment Request following:
Time: 8:00 a.m. to 6:00 p.m. • Standard language for all DSP–MRT
Agenda: To review and evaluate grant Periodically, the Substance Abuse and
Mental Health Services Administration questions;
applications.
Place: Doubletree by Hilton Washington (SAMHSA) will publish a summary of • New disparities module to align
DC—Crystal City, 300 Army Navy Drive, information collection requests under with SAMHSA’s monitoring
Arlington, VA 22202. OMB review, in compliance with the requirements;
Contact Person: Birgit Neuhuber, Ph.D., Paperwork Reduction Act (44 U.S.C. • Updated technical assistance
Scientific Review Officer, Scientific Review 35). To request a copy of these section;
Branch, NINDS/NIH/DHHS, Neuroscience documents, call the SAMHSA Reports • Deletion of cost questions specific
Center, 6001 Executive Blvd., Suite 3204, to funding amounts and in-kind
MSC 9529, Bethesda, MD 20892–9529,
Clearance Officer on (240) 276–1243.
resources;
neuhuber@ninds.nih.gov. Project: Project—Division of State • Deletion of advisory council and
Name of Committee: National Institute of Programs—Management Reporting other workgroup sub-committee
Neurological Disorders and Stroke Special Tool (DSP–MRT) (OMB No. 0930–
Emphasis Panel; NSD Member Conflict.
questions;
0354)—Revision • Addition of Section A specific to
sradovich on DSK3GMQ082PROD with NOTICES
Date: July 12, 2017.
Time: 12:00 p.m. to 2:00 p.m. The Substance Abuse and Mental SPF-Rx questions;
Agenda: To review and evaluate grant Health Services Administration • Addition of Section B specific to
applications. (SAMHSA)’s Center for Substance PDO questions;
VerDate Sep<11>2014 17:12 Jun 15, 2017 Jkt 241001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\16JNN1.SGM 16JNN1](https://thefederalregister.org/doc/82_FR_27828/page/2.svg)
Document Created: 2017-06-16 00:51:59
Document Modified: 2017-06-16 00:51:59
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | June 26-27, 2017. | |
| FR Citation | 82 FR 27713 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR